Simplified aminocoumarin analogues as anticancer agents: Amino isosteric replacement in the noviose moiety resulted in substantial enhancement of antiproliferative activity

Chinese Chemical Letters

Volumn 24, Issue 8, 2013, Pages 719-722

  Zhang, Ting ^a   Yan, Zheng ^a   Li, Yun Feng ^a   Wang, Nan ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

3 Amino 3 deoxy l noviose; Aminocoumarin analogues; Cytotoxicity; Hsp90 inhibitors

Indexed keywords

EID: 84879932672     PISSN: 10018417     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cclet.2013.04.046     Document Type: Article

References (17)

1. A. Maxwell DNA gyrase as a drug target Trends Microbiol. 5 1997 102 109
2. H. Hoeksema, J.L. Johnson, and J.W. Hinman Structural studies on streptonivicin, a new antibiotic J. Am. Chem. Soc. 77 1955 6710 6711
3. P. Laurin, D. Ferroud, and B. Musicki Structure activity relationship in two series of aminoalkyl substituted coumar inhibitors of gyrase B Bioorg. Med. Chem. Lett. 9 1999 2875 2880
4. M.G. Marcu, T.W. Schulte, and L. Neckers Novobiocin and related coumarins and depletion of heat shock protein 90-dependent signaling proteins J. Natl. Cancer Inst. 92 2000 242 248
5. M.G. Marcu, A. Chadli, and L. Neckers The heat shock protein 90 antagonist novobiocin interacts with a previously unrecognized ATP-binding domain in the carboxyl terminus of the chaperone J. Biol. Chem. 275 2000 37181 37186
6. L. Neckers, and K. Neckers Heat-shock protein 90 inhibitors as novel cancer chemotherapeutics - an update Expert Opin. Emerg. Drugs 10 2005 137 149
7. J.R. Smith, and P. Workman Targeting the cancer chaperone HSP90 Drug Discov. Today: Ther. Strateg. 4 2007 219 227
8. M.A. Biamonte, R. Van de Water, and J.W. Arndt Heat shock protein 90: inhibitors in clinical trials J. Med. Chem. 53 2010 3 17
9. X.M. Yu, G. Shen, and B.S.J. Blagg Hsp90 inhibitors identified from a library of novobiocin analogues J. Am. Chem. Soc. 127 2005 12778 12779
10. H.P. Zhao, B.R. Kusuma, and B.S.J. Blagg Synthesis and evaluation of noviose replacements on novobiocin that manifest antiproliferative activity Med. Chem. Lett. 1 2010 311 315
11. J.A. Burlison, L. Neckers, and B.S.J. Blagg Novobiocin: redesigning a DNA gyrase inhibitor for selective inhibition of Hsp90 J. Am. Chem. Soc. 128 2006 15529 15536
12. J.A. Burlison, C. Avila, and B.S.J. Blagg Development of novobiocin analogues that manifest anti-proliferative activity against several cancer cell lines J. Org. Chem. 73 2008 2130 2137
13. J.S. Luo, and X.M. Yu Concise and divergent approach to 3-O-acyl-l-noviose derivatives and their 3-amino bioisosteres: 3-O-benzoyl-l-noviose and N-benzoyl-3-amino-l-noviose Tetrahedron Lett. 52 2011 2450 2453
14. H. Tanimoto, and T. Oritani Practical synthesis of ambrox from farnesyl acetate involving lipase catalyzed resolution Tetrahedron: Asymm. 7 1996 1695 1704
15. L.B. Peterson, and B.S.J. Blagg Click chemistry to probe Hsp90: synthesis and evaluation of a series of triazole-containing novobiocin analogues Bioorg. Med. Chem. Lett. 20 2010 3957 3960
16. Y.Q. He, Y.Q. Li, and X.M. Yu Synthesis of 4-des-hydroxyl clorobiocin analogues as possible bacterial DNA gyrase B and human Hsp90 inhibitors J. Chin. Pharm. Sci. 20 2011 218 225
17. H.P. Zhao, E. Moroni, and B.S.J. Blagg 3D-QSAR-assisted design, synthesis, and evaluation of novobiocin analogues ACS Med. Chem. Lett. 4 2013 57 62